These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35355067)

  • 1. A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with penicillins.
    Luxton T; King N; Wälti C; Jeuken L; Sandoe J
    J Antimicrob Chemother; 2022 May; 77(6):1532-1541. PubMed ID: 35355067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of the Effect of Therapeutic Drug Monitoring on Patient Health Outcomes during Treatment with Carbapenems.
    Luxton TN; King N; Wälti C; Jeuken LJC; Sandoe JAT
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of antiretrovirals for people with HIV.
    Kredo T; Van der Walt JS; Siegfried N; Cohen K
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the practical impact of adjusting beta-lactam dosages based on therapeutic drug monitoring in critically ill adult patients: a systematic review and meta-analysis of randomized clinical trials and observational studies.
    Gulyás E; Horváth IL; Engh MA; Bunduc S; Dembrovszky F; Fehérvári P; Bánvölgyi A; Csupor D; Hegyi P; Karvaly GB
    Sci Rep; 2024 Apr; 14(1):7793. PubMed ID: 38565898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Therapeutic Drug Monitoring and Cytochrome P450 2C19 Genotyping on Clinical Outcomes of Voriconazole: A Systematic Review.
    Lee J; Ng P; Hamandi B; Husain S; Lefebvre MJ; Battistella M
    Ann Pharmacother; 2021 Apr; 55(4):509-529. PubMed ID: 32772568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
    Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
    Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol for ADAPT-TDM: A beta-lactam antibiotic Dose AdaPtation feasibility randomised controlled Trial using Therapeutic Drug Monitoring.
    Pai Mangalore R; Chai MG; Pope J; Lee SJ; Padiglione A; Diehl A; Roberts L; Sim K; Rawson-Harris P; Wicha S; Schneider HG; Peel TN; Jenney A; Ayton D; Peleg AY; Udy AA
    BMJ Open; 2024 Jul; 14(6):e083635. PubMed ID: 38951004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic review.
    Carland JE; Carland DJ; Brett J; Stocker SL; Roberts DM; Day RO; Laba TL
    Br J Clin Pharmacol; 2024 Sep; 90(9):2038-2066. PubMed ID: 38984480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
    Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
    Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis.
    Pai Mangalore R; Ashok A; Lee SJ; Romero L; Peel TN; Udy AA; Peleg AY
    Clin Infect Dis; 2022 Nov; 75(10):1848-1860. PubMed ID: 35731853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes.
    Giraud EL; Westerdijk K; van der Kleij MBA; Guchelaar NAD; Meertens M; Bleckman RF; Rieborn A; Mohammadi M; Roets E; Mathijssen RHJ; Huitema ADR; Koolen SLW; Gelderblom H; Moes DJAR; Reyners AKL; Touw DJ; Keizer-Heldens P; Oosten AW; van der Graaf WTA; Steeghs N; van Erp NP; Desar IME;
    ESMO Open; 2024 Jun; 9(6):103477. PubMed ID: 38833964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes With Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Systematic Review With Meta-Analysis.
    Ricciuto A; Dhaliwal J; Walters TD; Griffiths AM; Church PC
    J Crohns Colitis; 2018 Nov; 12(11):1302-1315. PubMed ID: 30107416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis.
    Dong W; Hu X; Wu C; Wang G; Fang Y; Shi L; Nie X
    Semin Arthritis Rheum; 2023 Dec; 63():152302. PubMed ID: 37951128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen.
    Bognàr TT; Kingma JSJ; Smeijsters EHE; van der Elst KCMK; de Kanter CTMK; Lindemans CAC; Egberts ACGT; Bartelink IHI; Lalmohamed AA
    Bone Marrow Transplant; 2023 Jul; 58(7):762-768. PubMed ID: 37002411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to design a study to evaluate therapeutic drug monitoring in infectious diseases?
    Märtson AG; Sturkenboom MGG; Stojanova J; Cattaneo D; Hope W; Marriott D; Patanwala AE; Peloquin CA; Wicha SG; van der Werf TS; Tängdén T; Roberts JA; Neely MN; Alffenaar JC
    Clin Microbiol Infect; 2020 Aug; 26(8):1008-1016. PubMed ID: 32205294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of daptomycin therapeutic drug monitoring on clinical outcomes: a systematic review.
    Cairns KA; Abbott IJ; Dooley MJ; Peleg AY; Peel TN; Udy AA
    Int J Antimicrob Agents; 2023 Feb; 61(2):106712. PubMed ID: 36640849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort.
    Meertens M; Giraud EL; van der Kleij MBA; Westerdijk K; Guchelaar NAD; Bleckman RF; Rieborn A; Imholz ALT; Otten HM; Vulink A; Los M; Hamberg P; van der Graaf WTA; Gelderblom H; Moes DJAR; Broekman KE; Touw DJ; Koolen SLW; Mathijssen RHJ; Huitema ADR; van Erp NP; Desar IME; Steeghs N;
    Clin Pharmacokinet; 2024 Jul; 63(7):1045-1054. PubMed ID: 39012619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of therapeutic drug monitoring-based antibiotic regimen in critically ill patients: a systematic review and meta-analysis of randomized controlled trials.
    Takahashi N; Kondo Y; Kubo K; Egi M; Kano KI; Ohshima Y; Nakada TA
    J Intensive Care; 2023 Nov; 11(1):48. PubMed ID: 37936203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.